US20050075716A1 - Flexible stent structure - Google Patents

Flexible stent structure Download PDF

Info

Publication number
US20050075716A1
US20050075716A1 US10/405,902 US40590203A US2005075716A1 US 20050075716 A1 US20050075716 A1 US 20050075716A1 US 40590203 A US40590203 A US 40590203A US 2005075716 A1 US2005075716 A1 US 2005075716A1
Authority
US
United States
Prior art keywords
prosthesis
radially expansible
luminal prosthesis
links
hinge regions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/405,902
Inventor
John Yan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avantec Vascular Corp
Original Assignee
Avantec Vascular Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantec Vascular Corp filed Critical Avantec Vascular Corp
Priority to US10/405,902 priority Critical patent/US20050075716A1/en
Publication of US20050075716A1 publication Critical patent/US20050075716A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped

Definitions

  • the present invention relates generally to medical devices and methods. More particularly, the present invention relates to radially expansible luminal prostheses, such as vascular stents and grafts.
  • Luminal prostheses are provided for a variety of medical purposes.
  • luminal stents can be placed in various body lumens, such as blood vessels, the ureter, urethra, biliary tract, and gastrointestinal tract, for maintaining patency.
  • Luminal stents are particularly useful for placement in atherosclerotic sites in blood vessels or fistula or bypass grafts.
  • Luminal grafts can be placed in blood vessels to provide support in diseased regions, such as aortic abdominal, and other aneurysms.
  • Both stent and graft prostheses must meet certain mechanical criteria to function successfully.
  • such prostheses should be at least partly flexible or articulated (i.e., adjacent expansible ring segments are connected by links that articulate relative to one another) over their lengths so that they may be advanced through tortuous body lumens, such as those of the coronary vasculature.
  • the prostheses should have controllable length change properties, either to maintain their original length or to have the ability to elongate or foreshorten, as desired, when the prostheses assume an expanded configuration.
  • Such prostheses must have sufficient mechanical strength, particularly hoop strength after they are expanded, in order to mechanically augment the luminal wall strength and thus maintain lumen patency.
  • Prior luminal prostheses often have structures which present a risk of injury as they are endoluminally delivered (i.e., tracked) to and/or released at a target site within a patient's body lumen.
  • many vascular stents comprise a plurality of circumferentially connected and spaced-apart ring segments which deform circumferentially as the stent is radially expanded.
  • the Palmaz stent described in U.S. Pat. Nos. 5,102,417 and 4,776,337 is typical of such stents.
  • Such stent designs can present challenges in both delivery and deployment.
  • flaring occurs when the longitudinal elements of the distal or proximal end of the prosthesis are bent outward to assume a crown-like configuration due to bending forces placed on these elements as the prosthesis passes through tortuous body passageways. Flaring can create the same deleterious effects as the previously described fish scaling phenomenon, injuring or traumatizing the blood vessel wall as the prosthesis is delivered or tracked within the blood vessel. In addition, flaring may increase a tendency for stent movement relative to a delivery balloon, thus causing an improperly deployed stent or, possibly, dislodging the undeployed stent completely from the catheter.
  • prior luminal prostheses can suffer problems during expansion, particularly during balloon expansion of malleable stents.
  • balloon expansion of vascular stents often results in the ends of the stent expanding preferentially compared to the center of the stent.
  • Such “dog-bone” expansion inhibits sufficient expansion of the center or ends of the stent, thus leaving a restricted luminal area in the fully deployed stent.
  • the ability to program stent expansion over the length of the stent has generally been lacking in prior stent designs.
  • a still further problem experienced by many prior stent designs is a lack of vessel coverage after expansion. It will be appreciated that the ability to support luminal patency and inhibit hyperplasia and other luminal in-growth can be enhanced if relative coverage of the luminal wall area by the expanded stent is increased. Thus, stent designs which afford a greater luminal wall coverage, or which minimize the free space between stent structures, while minimizing the amount of stent material used may be advantageous. Such increase of luminal wall coverage, however, should not be achieved at the expense of “crimpability.” Particularly for vascular applications, it is desirable that the diameter of the stent be reduced as much as possible during delivery, e.g., when crimped over a delivery balloon.
  • both trackability and the ability to cross smaller lesions and access more distal lesions will be enhanced.
  • a larger crimped-stent diameter may increase the risk of stent movement relative to the deployment balloon which, in turn, could cause an improperly deployed stent or even loss of the undeployed stent from the catheter.
  • the ability to reduce the stent diameter is generally limited by the amount of material in the stent itself. Thus, designs which increase the ability of the stent to cover the luminal wall without significantly reducing the “crimpability” would be particularly desirable.
  • the design should be such that the expanded prostheses will conform to both curved and straight vessels with minimal or no straightening or other unintended deformation of the vessel wall.
  • Such luminal prostheses should be trackable, preferably being both flexible and presenting minimum risk of injury to the luminal wall as they are being delivered.
  • the prostheses should avoid “fish scaling” and should be highly “crimpable” so that the prostheses diameter during delivery can be reduced.
  • the luminal prostheses will preferably further display superior expansion characteristics.
  • the prostheses designs should permit selective programming of the expansion characteristics along the length of the prostheses.
  • the designs should permit preferential expansion over the central portion of the prosthesis, or alternatively at either or both ends of the prostheses depending on the particular application in which the prosthesis is to be used.
  • the prostheses upon expansion should display superior luminal wall coverage and adequate to superior hoop strength in order to best maintain patency of the body lumen being treated. At least some of these objectives will be met by the luminal prostheses described and claimed hereinafter.
  • Stents having expansible ring segments joined by sigmoidal links and axial beams are described in WO 99/17680.
  • Stents comprising expansible rings including struts and hinges where the hinges are configured to have different opening forces are described in U.S. Pat. No. 5,922,020.
  • EP 662 307 describes an expansible stent having serpentine elements with varying degrees of curvature to provide controlled expansion characteristics.
  • WO 00/003,662 describes a stent delivery balloon which preferentially opens a center region of a stent as the balloon is expanded.
  • U.S. Pat. No. 6,017,365 describes a stent with serpentine segments with non-linear struts and sigmoidal links.
  • Other patents of interest include U.S. Pat. Nos. 4,776,337; 5,102,417; 6,017,362; 6,015,429; and 6,013,854.
  • the present invention provides improved luminal prostheses suitable for endoluminal placement within body lumens, particularly blood vessels, and most particularly coronary and peripheral arteries.
  • the luminal prostheses may be in the form of stents, intended for maintaining luminal patency, or may be in the form of grafts, intended for protecting or enhancing the strength of a luminal wall.
  • stent will be used to denote a vascular or other scaffold structure comprising expansible components, such as ring segments, which when expanded form an open lattice or framework which is disposed against the luminal wall.
  • graft will generally denote such as luminal scaffold which is covered by a liner, membrane, or other permeable or impermeable layer which covers at least a portion of the scaffold.
  • the drawings included herein are generally directed at stent structures, but it will be appreciated that corresponding graft structures could be provided by incorporating a liner, membrane, or the like, on either the outer or inner surfaces of the stent.
  • the luminal prostheses of the present invention will be radially expansible, usually by the application of a radially outward internal force to expand a minimally resilient (usually malleable) prosthesis structure.
  • a radially outward internal force will usually be provided by an inflatable balloon, and such balloon expansible stents are well-known in the art and described in the background references which have been cited above and are incorporated herein by reference.
  • at least some of the radially expansible luminal prostheses of the present invention may be self-expanding.
  • the prosthesis By fabricating the prostheses from a resilient material, usually a metal, such as spring stainless steel, a nickel-titanium alloy (such as Nitinol® alloy), or the like, the prosthesis can be designed to have a large (fully expanded) diameter in an unconstrained state.
  • the diameter of the prosthesis can be reduced by applying a radial constraint, e.g., by placing the prosthesis within a sleeve, tube, or other constraining structure. In that way, the self-expanding prosthesis can be delivered while constrained and deployed by releasing the constraint at the target site within the body lumen.
  • the general principles of constructing self-expanding stents and other luminal prostheses are also well-known in the art and described in at least some of the background references which have previously been incorporated herein.
  • a radially expansible luminal prostheses comprises a plurality of serpentine ring segments including struts connected by hinge regions.
  • the struts may be straight or may have non-linear configurations, e.g., being curved, wavy, or the like.
  • the use of non-linear struts may be advantageous in order to increase the area of the strut which engages the luminal wall after expansion without significantly reducing flexibility and/or crimpability of the strut.
  • the hinge regions are usually formed by a short curved or C-shaped region which permits the connected struts to reverse direction in order to define the serpentine ring pattern.
  • Adjacent serpentine rings are joined by sigmoidal links, i.e., S-shaped elements which may be malleable or elastically deformable in order to allow the adjacent segments to flex relative to each other during prosthesis delivery and expansion.
  • the sigmoidal links are attached to a side of the hinge region, typically located at the point where the hinge attaches to or transforms into the strut.
  • the use of such sigmoidal links is beneficial since it permits the longitudinal expansion or contraction of the prosthesis to accommodate length changes as the prosthesis is expanded.
  • Such links further permit bending of the prosthesis since they allow differential motion of adjacent serpentine rings. Such flexibility is particularly advantageous since it allows improved tracking of the prosthesis as it is delivered to an endoluminal location.
  • the sigmoidal links also improve the conformability of the expanded prosthesis when placed in a native vessel, artificial graft, or other body lumen location.
  • Such a structure distinguishes prior art designs where a sigmoidal link is attached at or near the apex of the link. By attaching the sigmoidal link closer to the strut, the adjacent ring segments can be positioned closer to each other. Moreover, because the links attach away from the apex of the hinge region, stress at the apex is reduced and uniform expansion of each ring segment is enhanced.
  • the apexes of opposed hinge regions on adjacent serpentine rings will be circumferentially offset. That is, the hinge regions apices on at least some (often all) of the serpentine rings will be aligned with the trough regions on the adjacent serpentine ring. In this way, the hinge regions are circumferentially offset so that the circumferential length of the sigmoidal links connecting proximate hinge regions can be reduced.
  • Such a design also allows for adjacent serpentine rings to be closer together to allow for improved vessel coverage upon prosthesis expansion.
  • Such a design also permits an increase in the diameter of the curved portions of the sigmoidal link which further improves stress distribution and opening characteristics of the prosthesis.
  • the luminal prostheses of the present invention will both have the sigmoidal links attached to the sides of the hinge regions and have the hinge regions circumferentially offset in order to achieve the greatest improvement in flexibility, crimpability, and uniform expansion characteristics.
  • the sigmoidal links will preferably have a S-shaped geometry with two outer connecting legs joined to a central leg by U-shaped joints. In some instances, it might also be possible to provide Z-shaped sigmoidal links, but those will generally be less preferred. In connecting the sigmoidal links to the hinge regions of the serpentine rings, the outer connecting legs will generally be oriented in the annular or circumferential direction and attach to the hinge region on its side.
  • a radially expansible luminal prosthesis comprises a plurality of ring segments which are expansible in response to a radially outward force.
  • the ring segments may comprise serpentine rings, as generally described above, or may comprise zig-zag segments, box segments, or other conventional prosthesis ring patterns.
  • the expansion characteristics of the luminal prosthesis may be varied over the length of the prostheses by controlling or programming the characteristics of each of the adjacent expansible ring segments. For example, different ring segments can be controlled to have different cross-sectional areas, e.g., differing widths, thicknesses or both, so that the amount of radially outward force needed to open the stent is lesser or greater.
  • the strut length may be varied in order to control the force needed to open the stent. That is, ring segments having a greater strut length will open with a lesser force since the increased strut length will leverage the force applied to a hinge region so that the hinge region will open sooner.
  • Other techniques for controlling the expansion characteristics of an individual ring segment may also be employed, such as those described in U.S. Pat. No. 5,922,020, the full disclosure of which has previously been incorporated herein by reference.
  • the ring segments near either or both ends of the prosthesis may be programmed to open more or less readily so that, when applying a constant radially outward force along the length of the prosthesis, the stent will first open either at both ends or in the middle. It will be appreciated that by employing balloons which also have variable expansion characteristics, such as those described in WO 00/03662, a wide variety of prosthesis expansion characteristics can be provided over the length of the prosthesis.
  • FIGS. 1A and 1B are digital photographs of a coronary stent constructed in accordance with the principles of the present invention with FIG. 1A showing the stent in an unexpanded configuration and FIG. 1B showing the stent in an expanded configuration.
  • FIG. 2 is a “rolled out” view of a the exemplary scaffold structure of FIGS. 1A and 1B .
  • FIGS. 3A through 3C are “rolled out” views of second through fourth exemplary embodiments of scaffold structures which may be programmed to display differential expansion characteristics over the length of the prosthesis.
  • FIG. 4 is a detailed view of the scaffold structure of FIG. 2 showing preferred dimensions of the scaffold components.
  • FIG. 4A is a cross-sectional view of a hinge region of a scaffold structure of the present invention.
  • FIG. 5 is a detailed view similar to FIG. 4 , showing the optional incorporation of non-linear struts into the scaffold structure.
  • FIGS. 6A and 6B are detailed views showing the scaffold structure of FIG. 2 in its non-expanded configuration ( FIG. 6A ) and in its fully expanded configuration ( FIG. 6B ).
  • FIGS. 7A-7C show balloon expansion of a luminal prosthesis, such as that having the scaffold structure of FIG. 3A or FIG. 3B , which has been programmed so that it preferentially expands near its center.
  • the present invention provides luminal prostheses intended for endoluminal placement in body lumens, particularly within the vascular system for the treatment of cardiovascular disease, such as vascular stenoses, dissections, aneurysms, and the like.
  • the prostheses are also useful for placement in other body lumens, such as the ureter, urethra, biliary tract, gastrointestinal tract and the like, for the treatment of other conditions which may benefit from the introduction of a reinforcing or protective structure within the body lumen.
  • the prostheses are preferably placed endoluminally.
  • endoluminally will mean placement through a body opening or by percutaneous or cutdown procedures, wherein the prosthesis is translumenally advanced through the body lumen from a remote location to a target site in the lumen.
  • the prostheses will typically be introduced “endovascularly” using a catheter over a guidewire under fluoroscopic guidance.
  • the catheters and guidewires may be introduced through conventional access sites to the vascular system, such as through the femoral artery, or brachial, subclavian or radial arteries, for access to the coronary arteries.
  • a luminal prosthesis according to the present invention will usually comprise at least two radially expansible, usually cylindrical, ring segments.
  • the prostheses will have at least four, and often five, six, seven, eight, ten, or more ring segments. At least some of the ring segments will be adjacent to each other but others may be separated by other non-ring structures.
  • radially expansible it is meant that the segment can be converted from a small diameter configuration (used for endoluminal placement) to a radially expanded, usually cylindrical, configuration which is achieved when the prosthesis is implanted at the desired target site.
  • the prosthesis may be minimally resilient, e.g., malleable, thus requiring the application of an internal force to expand and set it at the target site.
  • the expansive force can be provided by a balloon, such as the balloon of an angioplasty catheter for vascular procedures.
  • the present invention preferably provides sigmoidal links between successive unit segments which are particularly useful to enhance flexibility and crimpability of the prosthesis.
  • the prosthesis can be self-expanding.
  • Such self-expanding structures are provided by utilizing a resilient material, such as a tempered stainless steel or a superelastic alloy such as a Nitinol® alloy, and forming the body segment so that it possesses its desired, radially-expanded diameter when it is unconstrained, i.e. released from the radially constraining forces of a sheath.
  • a resilient material such as a tempered stainless steel or a superelastic alloy such as a Nitinol® alloy
  • the dimensions of the luminal prosthesis will depend on its intended use. Typically, the prosthesis will have a length in the range from about 5 mm to 100 mm, usually being from about 8 mm to 50 mm, for vascular applications.
  • the small (radially collapsed) diameter of cylindrical prostheses will usually be in the range from about 0.5 mm to 10 mm, more usually being in the range from 0.8 mm to 1.25 mm for vascular applications.
  • the expanded diameter will usually be in the range from about 1.5 mm to 50 mm, preferably being in the range from about 2.5 mm to 30 mm for vascular applications.
  • the ring segments may be formed from conventional materials used for body lumen stents and grafts, typically being formed from malleable metals, such as 300 series stainless steel, or from resilient metals, such as superelastic and shape memory alloys, e.g., Nitinol® alloys, spring stainless steels, and the like. It is possible that the body segments could be formed from combinations of these metals, or combinations of these types of metals and other non-metallic materials. Additional structures for the body or unit segments of the present invention are illustrated in U.S. Pat. Nos. 5,195,417; 5,102,417; and 4,776,337, the full disclosures of which are incorporated herein by reference.
  • an exemplary luminal prosthesis 10 particularly intended for implantation in the coronary vasculature comprises from 4 to 50 ring segments 12 (with 7 being illustrated). Each ring segment 12 is joined to the adjacent ring segment by at least one of sigmoidal links 14 (with three being illustrated). Each ring segment 12 includes a plurality, e.g., six, strut/hinge units (described in more detail in connection with FIGS. 2-5 below), and two out of each six hinge/strut structures on each ring segment 12 will be joined by the sigmoidal links 14 to the adjacent ring segment.
  • FIG. 1A shows the prosthesis 10 in a collapsed or narrow diameter configuration while FIG. 1B shows the prosthesis in its expanded configuration.
  • the prosthesis 20 comprises serpentine ring segments 22 , where each ring segment has essentially identical characteristics.
  • the ring segments 22 comprise a plurality of linear struts 24 joined by curved hinge regions 26 and 26 a .
  • the hinge regions 26 are free from other structure, i.e., they are not linked to adjacent hinge regions or other prosthesis structure.
  • the hinge regions 26 a are connected or joined to sigmoidal links 28 which secure the adjacent ring segments 22 .
  • FIG. 1 In the embodiment of FIG.
  • each adjacent serpentine ring segment 22 is joined by three sigmoidal links 28 .
  • the number of lengths could vary from one, two, up to the total number of hinge regions, i.e., six in the illustrated embodiment of FIG. 2 .
  • the sigmoidal links 28 are adjoined to the hinge regions 26 a so that a first outer leg segment 30 connects to the hinge region at its base i.e., where the hinge opens into the strut 24 .
  • a second outer leg segment 32 is joined to hinge region 26 a on the adjacent serpentine ring 22 at the base of that hinge region.
  • the legs 30 and 32 are generally oriented in a circumferential or annular direction at the point where they attach to the hinge regions 26 a .
  • the legs are joined by a pair of U-shaped regions which join a central leg 34 to complete the sigmoidal link. This design of the sigmoidal link has a number of advantages.
  • the legs can move circumferentially past each other to accommodate radial crimping of the prosthesis as well as facilitate radial opening of the stent.
  • the structure permits axially shortening and elongation to permit bending of the prosthesis as it is being introduced through tortuous regions of a blood vessel or other body lumen.
  • the serpentine ring segments 22 are rotationally oriented relative to each other so that the apices on the hinge regions 26 and 26 a on the first ring segment are aligned with a trough region 34 on the adjacent ring segment.
  • Such relative rotational alignment of the ring segments 22 minimizes the circumferential length of the sigmoidal links 28 need to connect the opposed hinge regions. It will be appreciated that if the apices of opposed hinge regions 26 and 26 a were rotationally aligned, the length of the connecting leg 34 would have to be significantly longer. Minimizing the length permits optimum configuration of the sigmoidal link.
  • leg segments 30 and 32 each have flared ends 31 and 33 , respectively, which connect the sigmoidal link 28 to the adjoining hinge region 26 a .
  • the flared ends provide stress relief as the ring segments 22 and links 28 are expanded.
  • the dimensions of the hinges, struts, sigmoidal links, and the like, of the luminal prostheses of the present invention may vary considerably depending on the intended use. Exemplary dimensions intended for a coronary stent ( FIG. 4 ) are set forth in Table I below. TABLE I Exemplary Dimensions (mm) A B C Broad Range 0.025 to 1.25 0 to 6.5 0.075 to 1.25 Preferred Range 0.075 to 0.15 0.15 to 0.25 0.2 to 0.4 D E F Broad Range 0.1 to 6.5 0 to 6.5 0.025 to 0.65 Preferred Range 0.25 to 0.5 0.15 to 0.3 0.035 to 0.075
  • a luminal prosthesis 30 has a plurality of adjacent serpentine ring segments 32 a - 32 m .
  • Individual serpentine ring segments 32 a - 32 m will have different expansibility characteristics so that the prosthesis 30 will differentially open along its length in response to uniform opening forces.
  • the expansibility characteristics of the individual ring segments may be modified in a number of the different ways. In a first general approach, the yield profile(s) of some or all of the hinges in an individual ring segment can be modified relative to such profiles for others of the ring segments.
  • the lengths of the struts connecting the hinge regions can be increased or decreased to change the leveraged force applied to a hinge region when the prosthesis is being expanded by an internal radially outward force.
  • Other approaches, such as adjusting the radius of an arcuate hinge region are also known.
  • FIG. 4A is a cross-sectional view of the hinge region 26 or 26 a having a width W and a thickness T.
  • a hinge region 26 or 26 a having a smaller width W, and/or a smaller thickness T will have less resistance to opening than a hinge region which has a larger thickness T 2 and/or a small width W 2 .
  • the opening characteristics of the prosthesis can be programmed by adjusting the widths and/or thickness of the hinge regions in particular ring segments 22 .
  • the serpentine ring segments 32 a - 32 c and 32 k - 32 m have struts and hinge regions with a larger width than those of the middle ring segments of 32 d - 32 j .
  • the innermost ring segments 32 f - 32 h have the smallest widths for the struts and hinge regions.
  • the ring segments having the narrowest widths ( 32 f - 32 h ) will be the least stiff and have the least resistance to expansion in response to an internally applied force.
  • the prosthesis 30 when the prosthesis 30 is expanded over a balloon 42 on a balloon catheter 40 , the prosthesis will preferentially expand over the central region, as illustrated in FIG. 7A-7C .
  • the prosthesis 30 is shown in FIG. 7A prior to expansion.
  • the balloon 42 is partially expanded ( FIG. 7B )
  • the prosthesis 30 begins opening in its middle sections prior to its end sections.
  • FIG. 7C uniform expansion of the prosthesis 30 along its length can be achieved.
  • the luminal prosthesis 30 could be modified so that the end segments 32 a - 32 c and 32 k - 32 m open preferentially with respect to the central ring segments 32 d - 32 j .
  • opening characteristics such as tapered would also be possible.
  • a tapered opening could be achieved by providing a stiffness gradient where segments at one end, such as 32 a , are the least stiff with ring segments becoming progressively stiffer in the direction of ring segment 32 m.
  • Differential expansion of different ring segments can be achieved in a variety of ways.
  • the strut length could be varied.
  • the struts in end segments 50 a and 50 f are the longest, with the strut lengths in the inner ring segments 50 b - 50 e becoming progressively shorter. Ring segments having longer strut lengths will apply a greater force to the hinge regions of those struts in response to an equal radially outward expansion force.
  • FIG. 3B instead of selecting different widths or other cross-sectional dimensions for the hinge regions of the ring segment, the strut length could be varied.
  • the struts in end segments 50 a and 50 f are the longest, with the strut lengths in the inner ring segments 50 b - 50 e becoming progressively shorter. Ring segments having longer strut lengths will apply a greater force to the hinge regions of those struts in response to an equal radially outward expansion force.
  • the end ring segments 50 a and 50 f will preferentially open with respect to the inner ring segments 50 b - 50 e .
  • Still further ways for controlling the expansion characteristics of an individual ring segment could also be utilized.
  • the hinge regions could be weakened and/or strengthened, as described in detail in U.S. Pat. No. 5,922,020.
  • the diameters of the hinge regions could be varied in successive ring segments, as described generally in European patent application 662 307.
  • serpentine ring segments 60 can be programmed to have different expansion rates by adjusting the lengths of some, but not all, of the struts 64 in any ring.
  • the serpentine rings 60 will be joined by sigmoidal links 62 , generally as described above. Rather than having struts 64 with identical lengths, those struts which terminate in hinges 66 a which are not adjacent to the sigmoidal links 62 can be made longer than those struts 66 b which are adjacent the sigmoidal links. This ability offers an additional degree of freedom in programming the expansion rates of the individual serpentine rings as well as the overall prosthesis made from such rings.
  • the serpentine ring segments may employ non-linear struts.
  • ring segments 12 may comprise non-linear struts 50 which are joined by sigmoidal links 52 in a manner described above in connection with other embodiments of the present invention.
  • the use of non-linear struts is advantageous in that it increases the length and therefore the amount of strut available for engagement against a luminal wall without increasing the length of the prosthesis. The ability to increase the coverage of the stent against the luminal wall is well recognized in the art.
  • non-linear struts can reduce the crimped-stent diameter since the wall thickness of the stent itself can be decreased without loss of expanded hoop strength.
  • Another advantage of a non-linear strut design is that it increases the amount of material within the strut thus improving upon the fluoroscopy characteristics of the stent.
  • FIGS. 6A and 6B show a detailed section of two adjacent serpentine rings 22 , with the prosthesis shown in its fully collapsed or crimped condition in FIG. 6A and its fully expanded condition in FIG. 6B .
  • an outward radial force is applied to the prosthesis. This radial force causes the hinge regions of the serpentine rings to flex open as the prosthesis is expanded.
  • the stresses within the hinge region become higher than the yield strength and enter the plastic region of the material. This allows the prosthesis to remain open following removal of the delivery balloon.
  • a shape-memory or other resilient alloy such as Nitinol®
  • the natural state of the prosthesis is in the expanded configuration.
  • a sheath is holding the prosthesis in a crimped configuration for delivery to the lesion site. Once the desired deployment location has been reached, the sheath is retracted and the prosthesis is expanded to its natural position.
  • the hinges act as springs in causing such expansion.

Abstract

Luminal prostheses comprise adjacent expansible segments, typically serpentine ring segments joined by sigmoidal links. By properly orienting the sigmoidal links and aligning hinge regions on adjacent serpentine rings, enhanced opening characteristics can be obtained. Additionally, by varying the mechanical characteristics of adjacent serpentine rings, program expansion of the luminal prostheses over their lengths may be obtained. The disclosed prostheses also have controllable opening characteristics and can be crimped to small diameters.

Description

    CROSS-REFERENCES TO RELATED APPLICATIONS
  • The present application is a continuation of U.S. patent application Ser. No. 09/565,560 (Attorney Docket No. 020460-000100/______), filed May 4, 2000, the full disclosure of which is incorporated herein by reference.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates generally to medical devices and methods. More particularly, the present invention relates to radially expansible luminal prostheses, such as vascular stents and grafts.
  • Luminal prostheses are provided for a variety of medical purposes. For example, luminal stents can be placed in various body lumens, such as blood vessels, the ureter, urethra, biliary tract, and gastrointestinal tract, for maintaining patency. Luminal stents are particularly useful for placement in atherosclerotic sites in blood vessels or fistula or bypass grafts. Luminal grafts can be placed in blood vessels to provide support in diseased regions, such as aortic abdominal, and other aneurysms.
  • Both stent and graft prostheses must meet certain mechanical criteria to function successfully. In particular, such prostheses should be at least partly flexible or articulated (i.e., adjacent expansible ring segments are connected by links that articulate relative to one another) over their lengths so that they may be advanced through tortuous body lumens, such as those of the coronary vasculature. In addition, the prostheses should have controllable length change properties, either to maintain their original length or to have the ability to elongate or foreshorten, as desired, when the prostheses assume an expanded configuration. Further such prostheses must have sufficient mechanical strength, particularly hoop strength after they are expanded, in order to mechanically augment the luminal wall strength and thus maintain lumen patency. The ability to meet these requirements is severely limited in the case of stents and grafts which are delivered in a radially constrained or collapsed configuration. Such prostheses must radially expand at a target site within the body lumen, so any adaptations which are intended to enhance flexibility must not interfere with the ability to radially expand or to maintain strength once expanded.
  • Prior luminal prostheses often have structures which present a risk of injury as they are endoluminally delivered (i.e., tracked) to and/or released at a target site within a patient's body lumen. In particular, many vascular stents comprise a plurality of circumferentially connected and spaced-apart ring segments which deform circumferentially as the stent is radially expanded. The Palmaz stent described in U.S. Pat. Nos. 5,102,417 and 4,776,337, is typical of such stents. Such stent designs can present challenges in both delivery and deployment. For example a phenomenon called “flaring” occurs when the longitudinal elements of the distal or proximal end of the prosthesis are bent outward to assume a crown-like configuration due to bending forces placed on these elements as the prosthesis passes through tortuous body passageways. Flaring can create the same deleterious effects as the previously described fish scaling phenomenon, injuring or traumatizing the blood vessel wall as the prosthesis is delivered or tracked within the blood vessel. In addition, flaring may increase a tendency for stent movement relative to a delivery balloon, thus causing an improperly deployed stent or, possibly, dislodging the undeployed stent completely from the catheter.
  • In addition to challenges during delivery, prior luminal prostheses can suffer problems during expansion, particularly during balloon expansion of malleable stents. For example, it has been found that balloon expansion of vascular stents often results in the ends of the stent expanding preferentially compared to the center of the stent. Such “dog-bone” expansion inhibits sufficient expansion of the center or ends of the stent, thus leaving a restricted luminal area in the fully deployed stent. Conversely, sometimes it will be desired to flare the ends of the stent in order to lock the stent in place and prevent the ends of the stent from collapsing after deployment. The ability to program stent expansion over the length of the stent has generally been lacking in prior stent designs.
  • A still further problem experienced by many prior stent designs is a lack of vessel coverage after expansion. It will be appreciated that the ability to support luminal patency and inhibit hyperplasia and other luminal in-growth can be enhanced if relative coverage of the luminal wall area by the expanded stent is increased. Thus, stent designs which afford a greater luminal wall coverage, or which minimize the free space between stent structures, while minimizing the amount of stent material used may be advantageous. Such increase of luminal wall coverage, however, should not be achieved at the expense of “crimpability.” Particularly for vascular applications, it is desirable that the diameter of the stent be reduced as much as possible during delivery, e.g., when crimped over a delivery balloon. By minimizing the crimped-stent diameter, both trackability and the ability to cross smaller lesions and access more distal lesions will be enhanced. In addition, a larger crimped-stent diameter may increase the risk of stent movement relative to the deployment balloon which, in turn, could cause an improperly deployed stent or even loss of the undeployed stent from the catheter. The ability to reduce the stent diameter is generally limited by the amount of material in the stent itself. Thus, designs which increase the ability of the stent to cover the luminal wall without significantly reducing the “crimpability” would be particularly desirable.
  • For these reasons, it would be desirable to provide improved stent, graft, and other luminal prostheses. In particular, it would be desirable to provide improved luminal prostheses which exhibit a high degree of flexibility with minimum losses of hoop strength and luminal wall coverage after the prostheses are expanded. For example, the design should be such that the expanded prostheses will conform to both curved and straight vessels with minimal or no straightening or other unintended deformation of the vessel wall. Such luminal prostheses should be trackable, preferably being both flexible and presenting minimum risk of injury to the luminal wall as they are being delivered. In particular, the prostheses should avoid “fish scaling” and should be highly “crimpable” so that the prostheses diameter during delivery can be reduced. The luminal prostheses will preferably further display superior expansion characteristics. In particular, the prostheses designs should permit selective programming of the expansion characteristics along the length of the prostheses. For example, the designs should permit preferential expansion over the central portion of the prosthesis, or alternatively at either or both ends of the prostheses depending on the particular application in which the prosthesis is to be used. Still further preferably, upon expansion the prostheses should display superior luminal wall coverage and adequate to superior hoop strength in order to best maintain patency of the body lumen being treated. At least some of these objectives will be met by the luminal prostheses described and claimed hereinafter.
  • 2. Description of the Background Art
  • Stents having expansible ring segments joined by sigmoidal links and axial beams are described in WO 99/17680. Stents comprising expansible rings including struts and hinges where the hinges are configured to have different opening forces are described in U.S. Pat. No. 5,922,020. EP 662 307 describes an expansible stent having serpentine elements with varying degrees of curvature to provide controlled expansion characteristics. WO 00/003,662 describes a stent delivery balloon which preferentially opens a center region of a stent as the balloon is expanded. U.S. Pat. No. 6,017,365, describes a stent with serpentine segments with non-linear struts and sigmoidal links. Other patents of interest include U.S. Pat. Nos. 4,776,337; 5,102,417; 6,017,362; 6,015,429; and 6,013,854.
  • SUMMARY OF THE INVENTION
  • The present invention provides improved luminal prostheses suitable for endoluminal placement within body lumens, particularly blood vessels, and most particularly coronary and peripheral arteries. The luminal prostheses may be in the form of stents, intended for maintaining luminal patency, or may be in the form of grafts, intended for protecting or enhancing the strength of a luminal wall. Generally, the term “stent” will be used to denote a vascular or other scaffold structure comprising expansible components, such as ring segments, which when expanded form an open lattice or framework which is disposed against the luminal wall. In contrast, the term “graft” will generally denote such as luminal scaffold which is covered by a liner, membrane, or other permeable or impermeable layer which covers at least a portion of the scaffold. The drawings included herein are generally directed at stent structures, but it will be appreciated that corresponding graft structures could be provided by incorporating a liner, membrane, or the like, on either the outer or inner surfaces of the stent.
  • The luminal prostheses of the present invention will be radially expansible, usually by the application of a radially outward internal force to expand a minimally resilient (usually malleable) prosthesis structure. Such radially outward internal force will usually be provided by an inflatable balloon, and such balloon expansible stents are well-known in the art and described in the background references which have been cited above and are incorporated herein by reference. Alternatively, at least some of the radially expansible luminal prostheses of the present invention may be self-expanding. By fabricating the prostheses from a resilient material, usually a metal, such as spring stainless steel, a nickel-titanium alloy (such as Nitinol® alloy), or the like, the prosthesis can be designed to have a large (fully expanded) diameter in an unconstrained state. The diameter of the prosthesis can be reduced by applying a radial constraint, e.g., by placing the prosthesis within a sleeve, tube, or other constraining structure. In that way, the self-expanding prosthesis can be delivered while constrained and deployed by releasing the constraint at the target site within the body lumen. The general principles of constructing self-expanding stents and other luminal prostheses are also well-known in the art and described in at least some of the background references which have previously been incorporated herein.
  • In a first aspect of the present invention, a radially expansible luminal prostheses comprises a plurality of serpentine ring segments including struts connected by hinge regions. The struts may be straight or may have non-linear configurations, e.g., being curved, wavy, or the like. The use of non-linear struts may be advantageous in order to increase the area of the strut which engages the luminal wall after expansion without significantly reducing flexibility and/or crimpability of the strut. The hinge regions are usually formed by a short curved or C-shaped region which permits the connected struts to reverse direction in order to define the serpentine ring pattern. Adjacent serpentine rings are joined by sigmoidal links, i.e., S-shaped elements which may be malleable or elastically deformable in order to allow the adjacent segments to flex relative to each other during prosthesis delivery and expansion. The sigmoidal links are attached to a side of the hinge region, typically located at the point where the hinge attaches to or transforms into the strut. The use of such sigmoidal links is beneficial since it permits the longitudinal expansion or contraction of the prosthesis to accommodate length changes as the prosthesis is expanded. Such links further permit bending of the prosthesis since they allow differential motion of adjacent serpentine rings. Such flexibility is particularly advantageous since it allows improved tracking of the prosthesis as it is delivered to an endoluminal location. The sigmoidal links also improve the conformability of the expanded prosthesis when placed in a native vessel, artificial graft, or other body lumen location. Such a structure distinguishes prior art designs where a sigmoidal link is attached at or near the apex of the link. By attaching the sigmoidal link closer to the strut, the adjacent ring segments can be positioned closer to each other. Moreover, because the links attach away from the apex of the hinge region, stress at the apex is reduced and uniform expansion of each ring segment is enhanced.
  • In a second aspect of the present invention, the apexes of opposed hinge regions on adjacent serpentine rings will be circumferentially offset. That is, the hinge regions apices on at least some (often all) of the serpentine rings will be aligned with the trough regions on the adjacent serpentine ring. In this way, the hinge regions are circumferentially offset so that the circumferential length of the sigmoidal links connecting proximate hinge regions can be reduced. Such a design also allows for adjacent serpentine rings to be closer together to allow for improved vessel coverage upon prosthesis expansion. Such a design also permits an increase in the diameter of the curved portions of the sigmoidal link which further improves stress distribution and opening characteristics of the prosthesis. Preferably, the luminal prostheses of the present invention will both have the sigmoidal links attached to the sides of the hinge regions and have the hinge regions circumferentially offset in order to achieve the greatest improvement in flexibility, crimpability, and uniform expansion characteristics.
  • The sigmoidal links will preferably have a S-shaped geometry with two outer connecting legs joined to a central leg by U-shaped joints. In some instances, it might also be possible to provide Z-shaped sigmoidal links, but those will generally be less preferred. In connecting the sigmoidal links to the hinge regions of the serpentine rings, the outer connecting legs will generally be oriented in the annular or circumferential direction and attach to the hinge region on its side.
  • In a further aspect of the present invention, a radially expansible luminal prosthesis comprises a plurality of ring segments which are expansible in response to a radially outward force. The ring segments may comprise serpentine rings, as generally described above, or may comprise zig-zag segments, box segments, or other conventional prosthesis ring patterns. The expansion characteristics of the luminal prosthesis may be varied over the length of the prostheses by controlling or programming the characteristics of each of the adjacent expansible ring segments. For example, different ring segments can be controlled to have different cross-sectional areas, e.g., differing widths, thicknesses or both, so that the amount of radially outward force needed to open the stent is lesser or greater. Alternatively, in the case of serpentine or zig-zag ring patterns, the strut length may be varied in order to control the force needed to open the stent. That is, ring segments having a greater strut length will open with a lesser force since the increased strut length will leverage the force applied to a hinge region so that the hinge region will open sooner. Other techniques for controlling the expansion characteristics of an individual ring segment may also be employed, such as those described in U.S. Pat. No. 5,922,020, the full disclosure of which has previously been incorporated herein by reference. Depending on the objective, the ring segments near either or both ends of the prosthesis may be programmed to open more or less readily so that, when applying a constant radially outward force along the length of the prosthesis, the stent will first open either at both ends or in the middle. It will be appreciated that by employing balloons which also have variable expansion characteristics, such as those described in WO 00/03662, a wide variety of prosthesis expansion characteristics can be provided over the length of the prosthesis.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIGS. 1A and 1B are digital photographs of a coronary stent constructed in accordance with the principles of the present invention with FIG. 1A showing the stent in an unexpanded configuration and FIG. 1B showing the stent in an expanded configuration.
  • FIG. 2 is a “rolled out” view of a the exemplary scaffold structure of FIGS. 1A and 1B.
  • FIGS. 3A through 3C are “rolled out” views of second through fourth exemplary embodiments of scaffold structures which may be programmed to display differential expansion characteristics over the length of the prosthesis.
  • FIG. 4 is a detailed view of the scaffold structure of FIG. 2 showing preferred dimensions of the scaffold components.
  • FIG. 4A is a cross-sectional view of a hinge region of a scaffold structure of the present invention.
  • FIG. 5 is a detailed view similar to FIG. 4, showing the optional incorporation of non-linear struts into the scaffold structure.
  • FIGS. 6A and 6B are detailed views showing the scaffold structure of FIG. 2 in its non-expanded configuration (FIG. 6A) and in its fully expanded configuration (FIG. 6B).
  • FIGS. 7A-7C show balloon expansion of a luminal prosthesis, such as that having the scaffold structure of FIG. 3A or FIG. 3B, which has been programmed so that it preferentially expands near its center.
  • DESCRIPTION OF THE SPECIFIC EMBODIMENTS
  • The present invention provides luminal prostheses intended for endoluminal placement in body lumens, particularly within the vascular system for the treatment of cardiovascular disease, such as vascular stenoses, dissections, aneurysms, and the like. The prostheses, however, are also useful for placement in other body lumens, such as the ureter, urethra, biliary tract, gastrointestinal tract and the like, for the treatment of other conditions which may benefit from the introduction of a reinforcing or protective structure within the body lumen.
  • The prostheses are preferably placed endoluminally. As used herein, “endoluminally” will mean placement through a body opening or by percutaneous or cutdown procedures, wherein the prosthesis is translumenally advanced through the body lumen from a remote location to a target site in the lumen. In vascular procedures, the prostheses will typically be introduced “endovascularly” using a catheter over a guidewire under fluoroscopic guidance. The catheters and guidewires may be introduced through conventional access sites to the vascular system, such as through the femoral artery, or brachial, subclavian or radial arteries, for access to the coronary arteries.
  • A luminal prosthesis according to the present invention will usually comprise at least two radially expansible, usually cylindrical, ring segments. Typically, the prostheses will have at least four, and often five, six, seven, eight, ten, or more ring segments. At least some of the ring segments will be adjacent to each other but others may be separated by other non-ring structures.
  • By “radially expansible,” it is meant that the segment can be converted from a small diameter configuration (used for endoluminal placement) to a radially expanded, usually cylindrical, configuration which is achieved when the prosthesis is implanted at the desired target site. The prosthesis may be minimally resilient, e.g., malleable, thus requiring the application of an internal force to expand and set it at the target site. Typically, the expansive force can be provided by a balloon, such as the balloon of an angioplasty catheter for vascular procedures. As will be described below, the present invention preferably provides sigmoidal links between successive unit segments which are particularly useful to enhance flexibility and crimpability of the prosthesis.
  • Alternatively, the prosthesis can be self-expanding. Such self-expanding structures are provided by utilizing a resilient material, such as a tempered stainless steel or a superelastic alloy such as a Nitinol® alloy, and forming the body segment so that it possesses its desired, radially-expanded diameter when it is unconstrained, i.e. released from the radially constraining forces of a sheath. In order to remain anchored in the body lumen, the prosthesis will remain partially constrained by the lumen. The self-expanding prosthesis can be tracked and delivered in its radially constrained configuration, e.g., by placing the prosthesis within a delivery sheath or tube and removing the sheath at the target site.
  • The dimensions of the luminal prosthesis will depend on its intended use. Typically, the prosthesis will have a length in the range from about 5 mm to 100 mm, usually being from about 8 mm to 50 mm, for vascular applications. The small (radially collapsed) diameter of cylindrical prostheses will usually be in the range from about 0.5 mm to 10 mm, more usually being in the range from 0.8 mm to 1.25 mm for vascular applications. The expanded diameter will usually be in the range from about 1.5 mm to 50 mm, preferably being in the range from about 2.5 mm to 30 mm for vascular applications.
  • The ring segments may be formed from conventional materials used for body lumen stents and grafts, typically being formed from malleable metals, such as 300 series stainless steel, or from resilient metals, such as superelastic and shape memory alloys, e.g., Nitinol® alloys, spring stainless steels, and the like. It is possible that the body segments could be formed from combinations of these metals, or combinations of these types of metals and other non-metallic materials. Additional structures for the body or unit segments of the present invention are illustrated in U.S. Pat. Nos. 5,195,417; 5,102,417; and 4,776,337, the full disclosures of which are incorporated herein by reference.
  • Referring now to FIGS. 1A and 1B, an exemplary luminal prosthesis 10 particularly intended for implantation in the coronary vasculature comprises from 4 to 50 ring segments 12 (with 7 being illustrated). Each ring segment 12 is joined to the adjacent ring segment by at least one of sigmoidal links 14 (with three being illustrated). Each ring segment 12 includes a plurality, e.g., six, strut/hinge units (described in more detail in connection with FIGS. 2-5 below), and two out of each six hinge/strut structures on each ring segment 12 will be joined by the sigmoidal links 14 to the adjacent ring segment. FIG. 1A shows the prosthesis 10 in a collapsed or narrow diameter configuration while FIG. 1B shows the prosthesis in its expanded configuration.
  • Referring now to FIGS. 2 and 4, a first embodiment of a luminal prosthesis 20 constructed in accordance with the principles of the present invention will be described in detail. The prosthesis 20 comprises serpentine ring segments 22, where each ring segment has essentially identical characteristics. The ring segments 22 comprise a plurality of linear struts 24 joined by curved hinge regions 26 and 26 a. As illustrated also in FIG. 4, the hinge regions 26 are free from other structure, i.e., they are not linked to adjacent hinge regions or other prosthesis structure. The hinge regions 26 a, in contrast, are connected or joined to sigmoidal links 28 which secure the adjacent ring segments 22. In the embodiment of FIG. 2, each adjacent serpentine ring segment 22 is joined by three sigmoidal links 28. The number of lengths, however, could vary from one, two, up to the total number of hinge regions, i.e., six in the illustrated embodiment of FIG. 2.
  • The sigmoidal links 28 are adjoined to the hinge regions 26 a so that a first outer leg segment 30 connects to the hinge region at its base i.e., where the hinge opens into the strut 24. Similarly, a second outer leg segment 32 is joined to hinge region 26 a on the adjacent serpentine ring 22 at the base of that hinge region. The legs 30 and 32 are generally oriented in a circumferential or annular direction at the point where they attach to the hinge regions 26 a. The legs are joined by a pair of U-shaped regions which join a central leg 34 to complete the sigmoidal link. This design of the sigmoidal link has a number of advantages. For example, by orienting the leg segments 30 and 32 circumferentially, the legs can move circumferentially past each other to accommodate radial crimping of the prosthesis as well as facilitate radial opening of the stent. Additionally, the structure permits axially shortening and elongation to permit bending of the prosthesis as it is being introduced through tortuous regions of a blood vessel or other body lumen.
  • As also best seen in FIG. 4, the serpentine ring segments 22 are rotationally oriented relative to each other so that the apices on the hinge regions 26 and 26 a on the first ring segment are aligned with a trough region 34 on the adjacent ring segment. Such relative rotational alignment of the ring segments 22 minimizes the circumferential length of the sigmoidal links 28 need to connect the opposed hinge regions. It will be appreciated that if the apices of opposed hinge regions 26 and 26 a were rotationally aligned, the length of the connecting leg 34 would have to be significantly longer. Minimizing the length permits optimum configuration of the sigmoidal link. By minimizing the length of the connecting legs of the sigmoidal link, the crimped diameter can be minimized as the sigmoidal links will not be interfering with the crimped configuration. In addition, by having shorter connecting legs on the sigmoidal link, the gaps between adjacent ring segments on the expanded prosthesis will be minimized. Preferably, leg segments 30 and 32 each have flared ends 31 and 33, respectively, which connect the sigmoidal link 28 to the adjoining hinge region 26 a. The flared ends provide stress relief as the ring segments 22 and links 28 are expanded.
  • The dimensions of the hinges, struts, sigmoidal links, and the like, of the luminal prostheses of the present invention may vary considerably depending on the intended use. Exemplary dimensions intended for a coronary stent (FIG. 4) are set forth in Table I below.
    TABLE I
    Exemplary Dimensions (mm)
    A B C
    Broad Range 0.025 to 1.25   0 to 6.5 0.075 to 1.25 
    Preferred Range 0.075 to 0.15 0.15 to 0.25 0.2 to 0.4
    D E F
    Broad Range  0.1 to 6.5   0 to 6.5 0.025 to 0.65 
    Preferred Range 0.25 to 0.5 0.15 to 0.3  0.035 to 0.075
  • Referring now to FIGS. 3A through 3C, embodiments of the luminal prostheses of the present invention where adjacent serpentine ring segments have different expansion characteristics will be described. In FIG. 3A, a luminal prosthesis 30 has a plurality of adjacent serpentine ring segments 32 a-32 m. Individual serpentine ring segments 32 a-32 m will have different expansibility characteristics so that the prosthesis 30 will differentially open along its length in response to uniform opening forces. The expansibility characteristics of the individual ring segments may be modified in a number of the different ways. In a first general approach, the yield profile(s) of some or all of the hinges in an individual ring segment can be modified relative to such profiles for others of the ring segments. This can be done by increasing or decreasing the width, thickness, or other cross-sectional dimension of any one or more of the hinge regions. Alternatively, the lengths of the struts connecting the hinge regions can be increased or decreased to change the leveraged force applied to a hinge region when the prosthesis is being expanded by an internal radially outward force. Other approaches, such as adjusting the radius of an arcuate hinge region are also known.
  • FIG. 4A is a cross-sectional view of the hinge region 26 or 26 a having a width W and a thickness T. A hinge region 26 or 26 a having a smaller width W, and/or a smaller thickness T, will have less resistance to opening than a hinge region which has a larger thickness T2 and/or a small width W2. Thus, as described above, the opening characteristics of the prosthesis can be programmed by adjusting the widths and/or thickness of the hinge regions in particular ring segments 22.
  • In the particular embodiment of FIG. 3A, the serpentine ring segments 32 a-32 c and 32 k-32 m have struts and hinge regions with a larger width than those of the middle ring segments of 32 d-32 j. The innermost ring segments 32 f-32 h have the smallest widths for the struts and hinge regions. Thus, assuming the prosthesis 30 is formed from the same material (or different materials having the same mechanical properties) over its entire length, the hinges of the ring segments 32 having greater widths will be stiffer and provide more resistant to expansion. In contrast, the ring segments having the narrowest widths (32 f-32 h) will be the least stiff and have the least resistance to expansion in response to an internally applied force. Thus, when the prosthesis 30 is expanded over a balloon 42 on a balloon catheter 40, the prosthesis will preferentially expand over the central region, as illustrated in FIG. 7A-7C. In particular, the prosthesis 30 is shown in FIG. 7A prior to expansion. As the balloon 42 is partially expanded (FIG. 7B), the prosthesis 30 begins opening in its middle sections prior to its end sections. Finally, after the balloon is fully expanded (FIG. 7C), uniform expansion of the prosthesis 30 along its length can be achieved. Of course, when expanded in a body lumen, full expansion of the prosthesis 30 may be constrained so that the center sections will first engage the wall with the end sections engaging the wall at a later time. Such deployment may be advantageous since it assures that the central regions of the prosthesis are fully engaged against the luminal wall prior to opening of the end portions.
  • Under other circumstances, however, it may be desired to preferentially open the end portions of the luminal prosthesis first. In such instances, the luminal prosthesis 30 could be modified so that the end segments 32 a-32 c and 32 k-32 m open preferentially with respect to the central ring segments 32 d-32 j. A variety of other opening characteristics, such as tapered would also be possible. For example, a tapered opening could be achieved by providing a stiffness gradient where segments at one end, such as 32 a, are the least stiff with ring segments becoming progressively stiffer in the direction of ring segment 32 m.
  • Differential expansion of different ring segments can be achieved in a variety of ways. For example, as shown in FIG. 3B, instead of selecting different widths or other cross-sectional dimensions for the hinge regions of the ring segment, the strut length could be varied. As shown in FIG. 3B, the struts in end segments 50 a and 50 f are the longest, with the strut lengths in the inner ring segments 50 b-50 e becoming progressively shorter. Ring segments having longer strut lengths will apply a greater force to the hinge regions of those struts in response to an equal radially outward expansion force. Thus, as shown in FIG. 3B, the end ring segments 50 a and 50 f will preferentially open with respect to the inner ring segments 50 b-50 e. Still further ways for controlling the expansion characteristics of an individual ring segment could also be utilized. For example, the hinge regions could be weakened and/or strengthened, as described in detail in U.S. Pat. No. 5,922,020. Alternatively, the diameters of the hinge regions could be varied in successive ring segments, as described generally in European patent application 662 307.
  • Referring now to FIG. 3C, serpentine ring segments 60 can be programmed to have different expansion rates by adjusting the lengths of some, but not all, of the struts 64 in any ring. The serpentine rings 60 will be joined by sigmoidal links 62, generally as described above. Rather than having struts 64 with identical lengths, those struts which terminate in hinges 66 a which are not adjacent to the sigmoidal links 62 can be made longer than those struts 66 b which are adjacent the sigmoidal links. This ability offers an additional degree of freedom in programming the expansion rates of the individual serpentine rings as well as the overall prosthesis made from such rings.
  • In an optional aspect of the present invention, at least some of the serpentine ring segments may employ non-linear struts. As shown in FIG. 5, ring segments 12 may comprise non-linear struts 50 which are joined by sigmoidal links 52 in a manner described above in connection with other embodiments of the present invention. The use of non-linear struts is advantageous in that it increases the length and therefore the amount of strut available for engagement against a luminal wall without increasing the length of the prosthesis. The ability to increase the coverage of the stent against the luminal wall is well recognized in the art. In addition, the use of non-linear struts can reduce the crimped-stent diameter since the wall thickness of the stent itself can be decreased without loss of expanded hoop strength. Another advantage of a non-linear strut design is that it increases the amount of material within the strut thus improving upon the fluoroscopy characteristics of the stent.
  • Referring now to FIGS. 6A and 6B, the improved expansion characteristics of the luminal prosthesis 20 of FIG. 2 will be described. It is assumed that the prosthesis 20 has been placed over a delivery balloon and that a constant expansion force over the length of the prosthesis is being applied. FIGS. 6A and 6B show a detailed section of two adjacent serpentine rings 22, with the prosthesis shown in its fully collapsed or crimped condition in FIG. 6A and its fully expanded condition in FIG. 6B. As pressure is applied to the delivery balloon, an outward radial force is applied to the prosthesis. This radial force causes the hinge regions of the serpentine rings to flex open as the prosthesis is expanded. For a material such as stainless steel, the stresses within the hinge region become higher than the yield strength and enter the plastic region of the material. This allows the prosthesis to remain open following removal of the delivery balloon. For a shape-memory or other resilient alloy, such as Nitinol®, the natural state of the prosthesis is in the expanded configuration. For such “self-expanding” designs, a sheath is holding the prosthesis in a crimped configuration for delivery to the lesion site. Once the desired deployment location has been reached, the sheath is retracted and the prosthesis is expanded to its natural position. The hinges act as springs in causing such expansion.
  • While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.

Claims (23)

1. A radially expansible luminal prosthesis including a scaffold comprising:
a plurality of serpentine ring segments including struts connected by circumferentially offset hinge regions, each hinge region having an apex and side regions disposed on either side of the of the apex; and
links between at least some of the hinge regions on adjacent serpentine rings, wherein the links are attached on the sides of the hinge regions, and all links have substantially similar sigmoidal shapes.
2. A radially expansible luminal prosthesis as in claim 1, wherein each sigmoidal link comprises two connecting legs and wherein each connecting leg is attached to a hinge region in a circumferential direction.
3. A radially expansible luminal prosthesis as in claim 2, wherein each sigmoidal link has a uniform width over its length.
4. A radially expansible luminal prosthesis as in claim 2, wherein each sigmoidal link has a flared end with joins to the hinge region.
5. A radially expansible luminal prosthesis as in claim 2, wherein the sigmoidal link is adapted to permit the connecting legs to move circumferentially past each other to accommodate radial crimping of the prosthesis.
6. A radially expansible luminal prosthesis as in claim 1, wherein the ring segments are expansible in response to a radially outward force;
wherein at least one of the ring segments opens at a different rate or in a different amount than at least one other ring segment when exposed to the same radially outward force.
7. A radially expansible luminal prosthesis as in claim 6, wherein at least some struts in at least some of the serpentine rings have different lengths to cause a different rate or amount of expansion.
8. A radially expansible luminal prosthesis as in claim 7, wherein at least some struts which are positioned away from the sigmoidal links are longer.
9. A radially expansible luminal prosthesis as in claim 6, wherein at least some of the struts have different widths than others of the struts to cause a different rate or amount of expansion.
10. A radially expansible luminal prosthesis as in claim 6, wherein at least some of the hinge regions have different widths than others of the hinges regions to cause a different rate or amount of expansion.
11. A radially expansible luminal prosthesis as in claim 1, wherein at least some of the struts are straight over the distance between the hinges.
12. A radially expansible luminal prosthesis as in claim 1, wherein at least some of the struts are non-linear.
13. A radially expansible luminal prosthesis as in claim 1, wherein the sigmoidal links are individually axially expansible and contractable.
14. A radially expansible luminal prosthesis including a scaffold comprising:
a plurality of serpentine ring segments including struts connected by hinge regions being circumferentially offset with apices and side regions disposed on either side of the apices; and
links extending between and connecting at least some of the hinge regions on adjacent serpentine rings, wherein each link is attached on a side of each connected hinge region and wherein all the links have substantially similar sigmoidal shapes.
15. A radially expansible luminal prosthesis as in claim 14, wherein the connected hinge regions on adjacent serpentine rings are axially proximate one another.
16. A radially expansible luminal prosthesis as in claim 14, wherein less than all of the hinge regions of a serpentine ring are connected to hinge regions of an adjacent serpentine ring.
17. A radially expansible luminal prosthesis as in claim 14, wherein all of the hinge regions of a serpentine ring are connected to hinge regions of an adjacent serpentine ring.
18. A radially expansible luminal prosthesis as in claim 14, wherein a number of the connected hinge regions of the serpentine rings is constant along the length of the prosthesis.
19. A radially expansible luminal prosthesis as in claim 14, wherein a number of the connected hinge regions of the serpentine rings varies along the length of the prosthesis.
20. A radially expansible luminal prosthesis including a scaffold comprising:
a plurality of serpentine ring segments including struts connected by hinge regions having apices and side regions, wherein the side regions are disposed on either side of the of the apices; and
links between at least some of the hinge regions on adjacent serpentine rings, wherein the links are attached on the sides of the hinge regions and all links have substantially similar sigmoidal shapes.
21. A radially expansible luminal prosthesis as in claim 20, wherein opposed hinge regions on adjacent serpentine rings are circumferentially offset.
22. A radially expansible luminal prosthesis including a scaffold comprising:
a plurality of serpentine ring segments including struts and hinge regions disposed between the struts, each hinge region having an apex and side regions disposed on either side of the apex;
links extending from one of the side regions of at least some of the hinge regions and connecting at least some of the adjacent serpentine rings, wherein all links have substantially similar sigmoidal shapes; and
cells formed by a boundary defined by adjacently joined serpentine ring segments and a pair of radially adjacent links connecting the adjacent serpentine rings, wherein each cell has a shape which is a multiple of the smallest cell.
23. A radially expansible luminal prosthesis as in claim 22, wherein each cell has a substantially similar shape.
US10/405,902 2000-05-04 2003-04-01 Flexible stent structure Abandoned US20050075716A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/405,902 US20050075716A1 (en) 2000-05-04 2003-04-01 Flexible stent structure

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/565,560 US6602282B1 (en) 2000-05-04 2000-05-04 Flexible stent structure
US10/405,902 US20050075716A1 (en) 2000-05-04 2003-04-01 Flexible stent structure

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/565,560 Continuation US6602282B1 (en) 2000-05-04 2000-05-04 Flexible stent structure

Publications (1)

Publication Number Publication Date
US20050075716A1 true US20050075716A1 (en) 2005-04-07

Family

ID=27623313

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/565,560 Expired - Fee Related US6602282B1 (en) 2000-05-04 2000-05-04 Flexible stent structure
US10/405,902 Abandoned US20050075716A1 (en) 2000-05-04 2003-04-01 Flexible stent structure

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/565,560 Expired - Fee Related US6602282B1 (en) 2000-05-04 2000-05-04 Flexible stent structure

Country Status (1)

Country Link
US (2) US6602282B1 (en)

Cited By (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040193250A1 (en) * 1998-09-05 2004-09-30 Jomed Gmbh Methods and apparatus for a stent having an expandable web structure
US20040236407A1 (en) * 1998-09-05 2004-11-25 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US20060175727A1 (en) * 2001-09-28 2006-08-10 Abbott Laboratories Vascular Enterprises Limited Porous membranes for medical implants and methods of manufacture
US20060184232A1 (en) * 1998-09-05 2006-08-17 Abbott Laboratories Vascular Methods and apparatus for curved stent
US20070061003A1 (en) * 2005-09-15 2007-03-15 Cappella, Inc. Segmented ostial protection device
US20070088428A1 (en) * 2005-09-15 2007-04-19 Cappella, Inc. Intraluminal device with asymmetric cap portion
US20070100426A1 (en) * 2004-03-31 2007-05-03 Leon Rudakov Medical device
US20070100321A1 (en) * 2004-12-22 2007-05-03 Leon Rudakov Medical device
US20070135891A1 (en) * 1998-09-05 2007-06-14 Ralph Schneider Stent having an expandable web structure
WO2007087069A2 (en) 2006-01-20 2007-08-02 Icon Medical Corp. Biodegradable device
US20070191924A1 (en) * 2004-03-21 2007-08-16 Leon Rudakov Method for treating aneurysms
WO2007094740A1 (en) * 2006-02-15 2007-08-23 Merlin Md Pte Ltd Highly flexible stent
US20070219612A1 (en) * 2006-03-20 2007-09-20 Xtent, Inc. Apparatus and methods for deployment of linked prosthetic segments
US20070255388A1 (en) * 2004-03-31 2007-11-01 Merlin Md Pte Ltd Endovascular device with membrane
US20080077229A1 (en) * 2004-06-28 2008-03-27 Xtent, Inc. Custom-length self-expanding stent delivery systems with stent bumpers
US20080177373A1 (en) * 2007-01-19 2008-07-24 Elixir Medical Corporation Endoprosthesis structures having supporting features
US20080215135A1 (en) * 2005-02-17 2008-09-04 Jacques Seguin Device Allowing the Treatment of Bodily Conduits at an Area of a Bifurcation
WO2008112458A2 (en) 2007-03-09 2008-09-18 Icon Medical Corp Bioabsorbable coatings for medical devices
WO2008142566A1 (en) 2007-05-23 2008-11-27 Abbott Laboratories Vascular Enterprises Limited Flexible stent with elevated scaffolding properties
US20080294240A1 (en) * 2007-05-23 2008-11-27 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
US20090054966A1 (en) * 2006-02-13 2009-02-26 Merlin Md Pte Ltd. Endovascular device with membrane
US20090163992A1 (en) * 2007-12-20 2009-06-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having flexible connectors
US20090163996A1 (en) * 2007-12-20 2009-06-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
US20090228088A1 (en) * 2008-03-06 2009-09-10 Xtent, Inc. Apparatus having variable strut length and methods of use
WO2009152376A1 (en) 2008-06-12 2009-12-17 Elixir Medical Corporation Intravascular stent
US20100030324A1 (en) * 2008-08-04 2010-02-04 Jacques Seguin Method for treating a body lumen
US20100063582A1 (en) * 2008-09-05 2010-03-11 Merlin Md Pte Ltd Endovascular device
US20100114297A1 (en) * 2001-09-18 2010-05-06 Abbott Laboratories Vascular Enterprises Limited Stent
US20100249905A1 (en) * 2007-12-19 2010-09-30 Contiliano Joseph H Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US7850726B2 (en) 2007-12-20 2010-12-14 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having struts linked by foot extensions
US20100328087A1 (en) * 2009-06-28 2010-12-30 Oki Data Corporation Communication apparatus, connection control method for communication apparatus and method of determining state of communication plug relative to communication connector in communication apparatus
US20110022148A1 (en) * 2007-02-20 2011-01-27 Xtent, Inc. Thermo-mechanically controlled implants and methods of use
US8070794B2 (en) 2007-01-09 2011-12-06 Stentys S.A.S. Frangible bridge structure for a stent, and stent including such bridge structures
US8333798B2 (en) 2003-11-07 2012-12-18 Merlin Md Pte Ltd. Implantable medical devices with enhanced visibility, mechanical properties and biocompatability
US20120325774A1 (en) * 2006-01-31 2012-12-27 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Methods of making medical devices
US8636792B2 (en) 2007-01-19 2014-01-28 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
US8702781B2 (en) 2001-12-03 2014-04-22 J.W. Medical Systems Ltd. Apparatus and methods for delivery of multiple distributed stents
US8814930B2 (en) 2007-01-19 2014-08-26 Elixir Medical Corporation Biodegradable endoprosthesis and methods for their fabrication
US8956398B2 (en) 2001-12-03 2015-02-17 J.W. Medical Systems Ltd. Custom length stent apparatus
US9259339B1 (en) 2014-08-15 2016-02-16 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9339404B2 (en) 2007-03-22 2016-05-17 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US9480588B2 (en) 2014-08-15 2016-11-01 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9566179B2 (en) 2003-12-23 2017-02-14 J.W. Medical Systems Ltd. Devices and methods for controlling and indicating the length of an interventional element
US9700448B2 (en) 2004-06-28 2017-07-11 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US9730819B2 (en) 2014-08-15 2017-08-15 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9855156B2 (en) 2014-08-15 2018-01-02 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9943426B2 (en) 2015-07-15 2018-04-17 Elixir Medical Corporation Uncaging stent
CN110279501A (en) * 2019-07-18 2019-09-27 中科益安医疗科技(北京)股份有限公司 A kind of medical embedded coronary artery bracket
US10918505B2 (en) 2016-05-16 2021-02-16 Elixir Medical Corporation Uncaging stent
US10987208B2 (en) 2012-04-06 2021-04-27 Merlin Md Pte Ltd. Devices and methods for treating an aneurysm
US20240065866A1 (en) * 2019-02-28 2024-02-29 Renata Medical, Inc. Growth stent and valve for congenital narrowings

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US8382821B2 (en) 1998-12-03 2013-02-26 Medinol Ltd. Helical hybrid stent
US20050033399A1 (en) * 1998-12-03 2005-02-10 Jacob Richter Hybrid stent
US7828835B2 (en) * 2000-03-01 2010-11-09 Medinol Ltd. Longitudinally flexible stent
US7758627B2 (en) * 2000-03-01 2010-07-20 Medinol, Ltd. Longitudinally flexible stent
US8202312B2 (en) * 2000-03-01 2012-06-19 Medinol Ltd. Longitudinally flexible stent
US8496699B2 (en) * 2000-03-01 2013-07-30 Medinol Ltd. Longitudinally flexible stent
US6723119B2 (en) * 2000-03-01 2004-04-20 Medinol Ltd. Longitudinally flexible stent
US7621947B2 (en) * 2000-03-01 2009-11-24 Medinol, Ltd. Longitudinally flexible stent
US8920487B1 (en) 2000-03-01 2014-12-30 Medinol Ltd. Longitudinally flexible stent
US7141062B1 (en) * 2000-03-01 2006-11-28 Medinol, Ltd. Longitudinally flexible stent
US20020082678A1 (en) * 2000-12-22 2002-06-27 Motasim Sirhan Intravascular delivery of mizoribine
US6740114B2 (en) * 2001-03-01 2004-05-25 Cordis Corporation Flexible stent
US9242080B2 (en) 2001-05-22 2016-01-26 Sanostec Corp Nasal inserts
US8403954B2 (en) 2001-05-22 2013-03-26 Sanostec Corp. Nasal congestion, obstruction relief, and drug delivery
US7390331B2 (en) 2001-05-22 2008-06-24 Sanostec Corp Nasal inserts
US7842083B2 (en) 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
GB0121980D0 (en) 2001-09-11 2001-10-31 Cathnet Science Holding As Expandable stent
US7270668B2 (en) * 2001-12-03 2007-09-18 Xtent, Inc. Apparatus and methods for delivering coiled prostheses
US20030135266A1 (en) 2001-12-03 2003-07-17 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7309350B2 (en) 2001-12-03 2007-12-18 Xtent, Inc. Apparatus and methods for deployment of vascular prostheses
US7351255B2 (en) 2001-12-03 2008-04-01 Xtent, Inc. Stent delivery apparatus and method
US7182779B2 (en) 2001-12-03 2007-02-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US7147656B2 (en) 2001-12-03 2006-12-12 Xtent, Inc. Apparatus and methods for delivery of braided prostheses
US20040186551A1 (en) 2003-01-17 2004-09-23 Xtent, Inc. Multiple independent nested stent structures and methods for their preparation and deployment
US7294146B2 (en) 2001-12-03 2007-11-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
US8080048B2 (en) 2001-12-03 2011-12-20 Xtent, Inc. Stent delivery for bifurcated vessels
US6911040B2 (en) * 2002-01-24 2005-06-28 Cordis Corporation Covered segmented stent
US7025777B2 (en) 2002-07-31 2006-04-11 Unison Therapeutics, Inc. Flexible and conformable stent and method of forming same
US8105373B2 (en) 2002-12-16 2012-01-31 Boston Scientific Scimed, Inc. Flexible stent with improved axial strength
US7241308B2 (en) 2003-06-09 2007-07-10 Xtent, Inc. Stent deployment systems and methods
US9155639B2 (en) 2009-04-22 2015-10-13 Medinol Ltd. Helical hybrid stent
US9039755B2 (en) 2003-06-27 2015-05-26 Medinol Ltd. Helical hybrid stent
US6840569B1 (en) * 2003-07-22 2005-01-11 Arthur Donald Leigh Caravan
US7258697B1 (en) * 2003-12-22 2007-08-21 Advanced Cardiovascular Systems, Inc. Stent with anchors to prevent vulnerable plaque rupture during deployment
US20050149168A1 (en) * 2003-12-30 2005-07-07 Daniel Gregorich Stent to be deployed on a bend
US7323006B2 (en) 2004-03-30 2008-01-29 Xtent, Inc. Rapid exchange interventional devices and methods
US7763064B2 (en) 2004-06-08 2010-07-27 Medinol, Ltd. Stent having struts with reverse direction curvature
US7867272B2 (en) * 2004-10-26 2011-01-11 Cordis Corporation Stent having twist cancellation geometry
AR054656A1 (en) * 2005-04-03 2007-07-11 Liliana Rosa Grinfeld STENT FOR OSTIAL INJURIES AND VASCULAR FORKS
EP1932496B1 (en) * 2005-10-06 2021-12-01 Kaneka Corporation Stent to be placed in the living body
US9144508B2 (en) * 2007-07-19 2015-09-29 Back Bay Medical Inc. Radially expandable stent
HUE044621T2 (en) 2008-02-22 2019-11-28 Annexin Pharmaceuticals Ab Compounds and methods for the prevention or treatment of restenosis
US8821562B2 (en) 2008-09-25 2014-09-02 Advanced Bifurcation Systems, Inc. Partially crimped stent
US11298252B2 (en) 2008-09-25 2022-04-12 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
US8828071B2 (en) 2008-09-25 2014-09-09 Advanced Bifurcation Systems, Inc. Methods and systems for ostial stenting of a bifurcation
WO2010036982A1 (en) 2008-09-25 2010-04-01 Henry Bourang Partially crimped stent
CN103037815B (en) 2010-03-24 2015-05-13 高级分支系统股份有限公司 Methods and systems for treating a bifurcation with provisional side branch stenting
CN103037816B (en) 2010-03-24 2018-12-28 高级分支系统股份有限公司 System and method for handling furcation
CA2794078A1 (en) 2010-03-24 2011-09-29 Advanced Bifurcation Systems, Inc. Stent alignment during treatment of a bifurcation
JP2013529507A (en) 2010-06-21 2013-07-22 ゾリオン メディカル インコーポレイテッド Bioabsorbable implant
WO2012075311A2 (en) 2010-12-01 2012-06-07 Zorion Medical, Inc. Magnesium-based absorbable implants
EP2658484A1 (en) 2010-12-30 2013-11-06 Boston Scientific Scimed, Inc. Multi stage opening stent designs
WO2012109382A2 (en) 2011-02-08 2012-08-16 Advanced Bifurcation Systems, Inc. Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
EP2672932B1 (en) 2011-02-08 2018-09-19 Advanced Bifurcation Systems, Inc. System for treating a bifurcation with a fully crimped stent
CA2823535A1 (en) 2011-03-03 2012-09-07 Boston Scientific Scimed, Inc. Low strain high strength stent
US8790388B2 (en) 2011-03-03 2014-07-29 Boston Scientific Scimed, Inc. Stent with reduced profile
EP3381416B1 (en) 2017-03-29 2020-07-22 Cook Medical Technologies LLC Prosthesis with flexible stent
US10849769B2 (en) * 2017-08-23 2020-12-01 Vesper Medical, Inc. Non-foreshortening stent

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4776337A (en) * 1985-11-07 1988-10-11 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5102417A (en) * 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5603721A (en) * 1991-10-28 1997-02-18 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5607404A (en) * 1994-04-11 1997-03-04 Medtronic, Inc. Low friction inner lumen
US5697971A (en) * 1996-06-11 1997-12-16 Fischell; Robert E. Multi-cell stent with cells having differing characteristics
US5755781A (en) * 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US5776161A (en) * 1995-10-16 1998-07-07 Instent, Inc. Medical stents, apparatus and method for making same
US5911754A (en) * 1998-07-24 1999-06-15 Uni-Cath Inc. Flexible stent with effective strut and connector patterns
US5922020A (en) * 1996-08-02 1999-07-13 Localmed, Inc. Tubular prosthesis having improved expansion and imaging characteristics
US5931866A (en) * 1998-02-24 1999-08-03 Frantzen; John J. Radially expandable stent featuring accordion stops
US6013854A (en) * 1994-06-17 2000-01-11 Terumo Kabushiki Kaisha Indwelling stent and the method for manufacturing the same
US6015429A (en) * 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US6017362A (en) * 1994-04-01 2000-01-25 Gore Enterprise Holdings, Inc. Folding self-expandable intravascular stent
US6017364A (en) * 1983-12-09 2000-01-25 Endovascular Technologies, Inc. Intraluminal repair device and catheter
US6042597A (en) * 1998-10-23 2000-03-28 Scimed Life Systems, Inc. Helical stent design
US6066656A (en) * 1994-12-20 2000-05-23 The United States Of America As Represented By The Department Of Health And Human Services 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
US6066169A (en) * 1998-06-02 2000-05-23 Ave Connaught Expandable stent having articulated connecting rods
US6083259A (en) * 1998-11-16 2000-07-04 Frantzen; John J. Axially non-contracting flexible radially expandable stent
US6106548A (en) * 1997-02-07 2000-08-22 Endosystems Llc Non-foreshortening intraluminal prosthesis
US6217608B1 (en) * 1996-03-05 2001-04-17 Divysio Solutions Ulc Expandable stent and method for delivery of same
US6235053B1 (en) * 1998-02-02 2001-05-22 G. David Jang Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors
US6331189B1 (en) * 1999-10-18 2001-12-18 Medtronic, Inc. Flexible medical stent
US6342067B1 (en) * 1998-01-09 2002-01-29 Nitinol Development Corporation Intravascular stent having curved bridges for connecting adjacent hoops
US6679910B1 (en) * 1999-11-12 2004-01-20 Latin American Devices Llc Intraluminal stent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2703510B2 (en) 1993-12-28 1998-01-26 アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド Expandable stent and method of manufacturing the same
US6602281B1 (en) 1995-06-05 2003-08-05 Avantec Vascular Corporation Radially expansible vessel scaffold having beams and expansion joints
US5807404A (en) * 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
DE29708689U1 (en) * 1997-05-15 1997-07-17 Jomed Implantate Gmbh Coronary stent
DE29708879U1 (en) 1997-05-20 1997-07-31 Jomed Implantate Gmbh Coronary stent
US6136011A (en) 1998-07-14 2000-10-24 Advanced Cardiovascular Systems, Inc. Stent delivery system and method of use

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017364A (en) * 1983-12-09 2000-01-25 Endovascular Technologies, Inc. Intraluminal repair device and catheter
US5102417A (en) * 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4776337B1 (en) * 1985-11-07 2000-12-05 Cordis Corp Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4776337A (en) * 1985-11-07 1988-10-11 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5603721A (en) * 1991-10-28 1997-02-18 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US6017362A (en) * 1994-04-01 2000-01-25 Gore Enterprise Holdings, Inc. Folding self-expandable intravascular stent
US5607404A (en) * 1994-04-11 1997-03-04 Medtronic, Inc. Low friction inner lumen
US6013854A (en) * 1994-06-17 2000-01-11 Terumo Kabushiki Kaisha Indwelling stent and the method for manufacturing the same
US6015429A (en) * 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US6066656A (en) * 1994-12-20 2000-05-23 The United States Of America As Represented By The Department Of Health And Human Services 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
US5776161A (en) * 1995-10-16 1998-07-07 Instent, Inc. Medical stents, apparatus and method for making same
US6217608B1 (en) * 1996-03-05 2001-04-17 Divysio Solutions Ulc Expandable stent and method for delivery of same
US5697971A (en) * 1996-06-11 1997-12-16 Fischell; Robert E. Multi-cell stent with cells having differing characteristics
US5922020A (en) * 1996-08-02 1999-07-13 Localmed, Inc. Tubular prosthesis having improved expansion and imaging characteristics
US5755781A (en) * 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US6106548A (en) * 1997-02-07 2000-08-22 Endosystems Llc Non-foreshortening intraluminal prosthesis
US6342067B1 (en) * 1998-01-09 2002-01-29 Nitinol Development Corporation Intravascular stent having curved bridges for connecting adjacent hoops
US6235053B1 (en) * 1998-02-02 2001-05-22 G. David Jang Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors
US5931866A (en) * 1998-02-24 1999-08-03 Frantzen; John J. Radially expandable stent featuring accordion stops
US6066169A (en) * 1998-06-02 2000-05-23 Ave Connaught Expandable stent having articulated connecting rods
US5911754A (en) * 1998-07-24 1999-06-15 Uni-Cath Inc. Flexible stent with effective strut and connector patterns
US6042597A (en) * 1998-10-23 2000-03-28 Scimed Life Systems, Inc. Helical stent design
US6083259A (en) * 1998-11-16 2000-07-04 Frantzen; John J. Axially non-contracting flexible radially expandable stent
US6331189B1 (en) * 1999-10-18 2001-12-18 Medtronic, Inc. Flexible medical stent
US6679910B1 (en) * 1999-11-12 2004-01-20 Latin American Devices Llc Intraluminal stent

Cited By (127)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7887578B2 (en) 1998-09-05 2011-02-15 Abbott Laboratories Vascular Enterprises Limited Stent having an expandable web structure
US20060184232A1 (en) * 1998-09-05 2006-08-17 Abbott Laboratories Vascular Methods and apparatus for curved stent
US20050004650A1 (en) * 1998-09-05 2005-01-06 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for a stent having an expandable web structure and delivery system
US20050004655A2 (en) * 1998-09-05 2005-01-06 Abbott Labortories Vascular Enterprises Limited Methods and apparatus for a stent having an expandable web structure
US7789905B2 (en) 1998-09-05 2010-09-07 Abbottt Laboratories Vascular Enterprises Limited Apparatus for a stent having an expandable web structure
US20050043778A1 (en) * 1998-09-05 2005-02-24 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for a stent having an expandable web structure
US9517146B2 (en) 1998-09-05 2016-12-13 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US20070213800A1 (en) * 1998-09-05 2007-09-13 Abbott Laboratories Vascular Enterprises Limited Method and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US8303645B2 (en) 1998-09-05 2012-11-06 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for a stent having an expandable web structure
US7887577B2 (en) 1998-09-05 2011-02-15 Abbott Laboratories Vascular Enterprises Limited Apparatus for a stent having an expandable web structure
US8088157B2 (en) 1998-09-05 2012-01-03 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US8814926B2 (en) 1998-09-05 2014-08-26 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US20070135891A1 (en) * 1998-09-05 2007-06-14 Ralph Schneider Stent having an expandable web structure
US20070179601A1 (en) * 1998-09-05 2007-08-02 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protections coupled with improved protections against restenosis and trombus formation
US7927365B2 (en) 1998-09-05 2011-04-19 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US7927364B2 (en) 1998-09-05 2011-04-19 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US20050004658A1 (en) * 1998-09-05 2005-01-06 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for a drug-coated stent having an expandable web structure
US20040236407A1 (en) * 1998-09-05 2004-11-25 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US8343208B2 (en) 1998-09-05 2013-01-01 Abbott Laboratories Vascular Enterprises Limited Stent having an expandable web structure
US7789904B2 (en) 1998-09-05 2010-09-07 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for a stent having an expandable web structure
US20110004289A1 (en) * 1998-09-05 2011-01-06 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for a stent having an expandable web structure
US7846196B2 (en) 1998-09-05 2010-12-07 Abbott Laboratories Vascular Enterprises Limited Apparatus for a stent having an expandable web structure
US10420637B2 (en) 1998-09-05 2019-09-24 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US7842079B2 (en) 1998-09-05 2010-11-30 Abbott Laboratories Vascular Enterprises Limited Apparatus for a stent having an expandable web structure and delivery system
US7842078B2 (en) 1998-09-05 2010-11-30 Abbott Laboratories Vascular Enterprises Limited Apparatus for a stent having an expandable web structure and delivery system
US7815672B2 (en) 1998-09-05 2010-10-19 Abbott Laboratories Vascular Enterprises Limited Apparatus for a stent having an expandable web structure
US7794491B2 (en) 1998-09-05 2010-09-14 Abbott Laboratories Vascular Enterprises Limited Apparatus for a stent having an expandable web structure and delivery system
US7811314B2 (en) 1998-09-05 2010-10-12 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
US20040193250A1 (en) * 1998-09-05 2004-09-30 Jomed Gmbh Methods and apparatus for a stent having an expandable web structure
US9375330B2 (en) 1999-11-19 2016-06-28 Advanced Bio Prosthetic Surfaces, Ltd. Methods of making medical devices
US20100114297A1 (en) * 2001-09-18 2010-05-06 Abbott Laboratories Vascular Enterprises Limited Stent
US7815763B2 (en) 2001-09-28 2010-10-19 Abbott Laboratories Vascular Enterprises Limited Porous membranes for medical implants and methods of manufacture
US20110022159A1 (en) * 2001-09-28 2011-01-27 Abbott Laboratories Vascular Enterprises Limited Porous membranes for medical implants and methods of manufacture
US20060175727A1 (en) * 2001-09-28 2006-08-10 Abbott Laboratories Vascular Enterprises Limited Porous membranes for medical implants and methods of manufacture
US9326876B2 (en) 2001-12-03 2016-05-03 J.W. Medical Systems Ltd. Apparatus and methods for delivery of multiple distributed stents
US8956398B2 (en) 2001-12-03 2015-02-17 J.W. Medical Systems Ltd. Custom length stent apparatus
US8702781B2 (en) 2001-12-03 2014-04-22 J.W. Medical Systems Ltd. Apparatus and methods for delivery of multiple distributed stents
US8333798B2 (en) 2003-11-07 2012-12-18 Merlin Md Pte Ltd. Implantable medical devices with enhanced visibility, mechanical properties and biocompatability
US9566179B2 (en) 2003-12-23 2017-02-14 J.W. Medical Systems Ltd. Devices and methods for controlling and indicating the length of an interventional element
US20070191924A1 (en) * 2004-03-21 2007-08-16 Leon Rudakov Method for treating aneurysms
US20070255388A1 (en) * 2004-03-31 2007-11-01 Merlin Md Pte Ltd Endovascular device with membrane
US20070100426A1 (en) * 2004-03-31 2007-05-03 Leon Rudakov Medical device
US8500751B2 (en) 2004-03-31 2013-08-06 Merlin Md Pte Ltd Medical device
US9844433B2 (en) 2004-03-31 2017-12-19 Merlin Md Pte. Ltd. Medical device
US9585668B2 (en) 2004-03-31 2017-03-07 Merlin Md Pte Ltd Medical device
US10390934B2 (en) 2004-03-31 2019-08-27 Merlin Md Pte. Ltd. Medical device
US8715340B2 (en) 2004-03-31 2014-05-06 Merlin Md Pte Ltd. Endovascular device with membrane
US11033378B2 (en) 2004-03-31 2021-06-15 Merlin Md Pte Ltd. Medical device
US8915952B2 (en) 2004-03-31 2014-12-23 Merlin Md Pte Ltd. Method for treating aneurysms
US8920430B2 (en) 2004-03-31 2014-12-30 Merlin Md Pte. Ltd. Medical device
US9433518B2 (en) 2004-03-31 2016-09-06 Merlin Md Pte. Ltd. Medical device
US20090234428A1 (en) * 2004-06-28 2009-09-17 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US9700448B2 (en) 2004-06-28 2017-07-11 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US20080077229A1 (en) * 2004-06-28 2008-03-27 Xtent, Inc. Custom-length self-expanding stent delivery systems with stent bumpers
US8986362B2 (en) 2004-06-28 2015-03-24 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US20070100321A1 (en) * 2004-12-22 2007-05-03 Leon Rudakov Medical device
US20080215135A1 (en) * 2005-02-17 2008-09-04 Jacques Seguin Device Allowing the Treatment of Bodily Conduits at an Area of a Bifurcation
US9192492B2 (en) 2005-02-17 2015-11-24 Jacques Seguin Device allowing the treatment of bodily conduits at an area of a bifurcation
US20070088428A1 (en) * 2005-09-15 2007-04-19 Cappella, Inc. Intraluminal device with asymmetric cap portion
US20070061003A1 (en) * 2005-09-15 2007-03-15 Cappella, Inc. Segmented ostial protection device
WO2007087069A2 (en) 2006-01-20 2007-08-02 Icon Medical Corp. Biodegradable device
US8647700B2 (en) * 2006-01-31 2014-02-11 Advanced Bio Prosthetic Surfaces, Ltd. Methods of making medical devices
US20120325774A1 (en) * 2006-01-31 2012-12-27 Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. Methods of making medical devices
US20090054966A1 (en) * 2006-02-13 2009-02-26 Merlin Md Pte Ltd. Endovascular device with membrane
WO2007094740A1 (en) * 2006-02-15 2007-08-23 Merlin Md Pte Ltd Highly flexible stent
US20070219612A1 (en) * 2006-03-20 2007-09-20 Xtent, Inc. Apparatus and methods for deployment of linked prosthetic segments
US9883957B2 (en) 2006-03-20 2018-02-06 J.W. Medical Systems Ltd. Apparatus and methods for deployment of linked prosthetic segments
US8652198B2 (en) 2006-03-20 2014-02-18 J.W. Medical Systems Ltd. Apparatus and methods for deployment of linked prosthetic segments
US8070794B2 (en) 2007-01-09 2011-12-06 Stentys S.A.S. Frangible bridge structure for a stent, and stent including such bridge structures
US9119905B2 (en) * 2007-01-19 2015-09-01 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
CN104042375A (en) * 2007-01-19 2014-09-17 万能医药公司 Endoprosthesis structures having supporting features
US8323760B2 (en) 2007-01-19 2012-12-04 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
US20080177373A1 (en) * 2007-01-19 2008-07-24 Elixir Medical Corporation Endoprosthesis structures having supporting features
US9566371B2 (en) * 2007-01-19 2017-02-14 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
US20080177374A1 (en) * 2007-01-19 2008-07-24 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
US8636792B2 (en) 2007-01-19 2014-01-28 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
US8182890B2 (en) 2007-01-19 2012-05-22 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
WO2008089446A3 (en) * 2007-01-19 2008-10-09 Elixir Medical Corp Endoprosthesis structures having supporting features
US20150025619A1 (en) * 2007-01-19 2015-01-22 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
US20150320577A1 (en) * 2007-01-19 2015-11-12 Elixir Medical Corporation Biodegradable endoprostheses and methods for their fabrication
US8814930B2 (en) 2007-01-19 2014-08-26 Elixir Medical Corporation Biodegradable endoprosthesis and methods for their fabrication
US8980297B2 (en) 2007-02-20 2015-03-17 J.W. Medical Systems Ltd. Thermo-mechanically controlled implants and methods of use
US9457133B2 (en) 2007-02-20 2016-10-04 J.W. Medical Systems Ltd. Thermo-mechanically controlled implants and methods of use
US20110022148A1 (en) * 2007-02-20 2011-01-27 Xtent, Inc. Thermo-mechanically controlled implants and methods of use
WO2008112458A2 (en) 2007-03-09 2008-09-18 Icon Medical Corp Bioabsorbable coatings for medical devices
US9339404B2 (en) 2007-03-22 2016-05-17 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8016874B2 (en) 2007-05-23 2011-09-13 Abbott Laboratories Vascular Enterprises Limited Flexible stent with elevated scaffolding properties
US20080294240A1 (en) * 2007-05-23 2008-11-27 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
US8128679B2 (en) 2007-05-23 2012-03-06 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
WO2008142566A1 (en) 2007-05-23 2008-11-27 Abbott Laboratories Vascular Enterprises Limited Flexible stent with elevated scaffolding properties
US9320627B2 (en) 2007-05-23 2016-04-26 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
US20080294239A1 (en) * 2007-05-23 2008-11-27 Abbott Laboratories Vascular Enterprises Limited Flexible stent with elevated scaffolding properties
US7972373B2 (en) 2007-12-19 2011-07-05 Advanced Technologies And Regenerative Medicine, Llc Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US20100249905A1 (en) * 2007-12-19 2010-09-30 Contiliano Joseph H Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US7981149B2 (en) 2007-12-19 2011-07-19 Advanced Technologies And Regenerative Medicine, Llc Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US8337544B2 (en) 2007-12-20 2012-12-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having flexible connectors
US20090163992A1 (en) * 2007-12-20 2009-06-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having flexible connectors
US20090163996A1 (en) * 2007-12-20 2009-06-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
US8920488B2 (en) 2007-12-20 2014-12-30 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
US7850726B2 (en) 2007-12-20 2010-12-14 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having struts linked by foot extensions
US8246674B2 (en) 2007-12-20 2012-08-21 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having struts linked by foot extensions
US9101503B2 (en) * 2008-03-06 2015-08-11 J.W. Medical Systems Ltd. Apparatus having variable strut length and methods of use
US20090228088A1 (en) * 2008-03-06 2009-09-10 Xtent, Inc. Apparatus having variable strut length and methods of use
WO2009152376A1 (en) 2008-06-12 2009-12-17 Elixir Medical Corporation Intravascular stent
EP2296578A1 (en) * 2008-06-12 2011-03-23 Elixir Medical Corporation Intravascular stent
EP2296578A4 (en) * 2008-06-12 2014-01-15 Elixir Medical Corp Intravascular stent
US20100030324A1 (en) * 2008-08-04 2010-02-04 Jacques Seguin Method for treating a body lumen
US9005274B2 (en) 2008-08-04 2015-04-14 Stentys Sas Method for treating a body lumen
US8262692B2 (en) 2008-09-05 2012-09-11 Merlin Md Pte Ltd Endovascular device
US20100063582A1 (en) * 2008-09-05 2010-03-11 Merlin Md Pte Ltd Endovascular device
US20100328087A1 (en) * 2009-06-28 2010-12-30 Oki Data Corporation Communication apparatus, connection control method for communication apparatus and method of determining state of communication plug relative to communication connector in communication apparatus
US10987208B2 (en) 2012-04-06 2021-04-27 Merlin Md Pte Ltd. Devices and methods for treating an aneurysm
US20180360628A1 (en) * 2014-08-15 2018-12-20 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9855156B2 (en) 2014-08-15 2018-01-02 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9480588B2 (en) 2014-08-15 2016-11-01 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9259339B1 (en) 2014-08-15 2016-02-16 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9730819B2 (en) 2014-08-15 2017-08-15 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9943426B2 (en) 2015-07-15 2018-04-17 Elixir Medical Corporation Uncaging stent
US10918505B2 (en) 2016-05-16 2021-02-16 Elixir Medical Corporation Uncaging stent
US10786374B2 (en) 2016-05-16 2020-09-29 Elixir Medical Corporation Uncaging stent
US10076431B2 (en) 2016-05-16 2018-09-18 Elixir Medical Corporation Uncaging stent
US10383750B1 (en) 2016-05-16 2019-08-20 Elixir Medical Corporation Uncaging stent
US10271976B2 (en) 2016-05-16 2019-04-30 Elixir Medical Corporation Uncaging stent
US11622872B2 (en) 2016-05-16 2023-04-11 Elixir Medical Corporation Uncaging stent
US20240065866A1 (en) * 2019-02-28 2024-02-29 Renata Medical, Inc. Growth stent and valve for congenital narrowings
CN110279501A (en) * 2019-07-18 2019-09-27 中科益安医疗科技(北京)股份有限公司 A kind of medical embedded coronary artery bracket
WO2021008599A1 (en) * 2019-07-18 2021-01-21 史忠林 Medical implanted coronary stent

Also Published As

Publication number Publication date
US6602282B1 (en) 2003-08-05

Similar Documents

Publication Publication Date Title
US6602282B1 (en) Flexible stent structure
US6916336B2 (en) Vascular prosthesis
US5593442A (en) Radially expansible and articulated vessel scaffold
US6312459B1 (en) Stent design for use in small vessels
US6251134B1 (en) Stent with high longitudinal flexibility
US8721705B2 (en) Non-foreshortening intraluminal prosthesis
EP0969777B1 (en) Coiled sheet stent having helical articulation and methods of use
EP2268235B1 (en) Stent prosthesis having select flared crowns
US8343208B2 (en) Stent having an expandable web structure
US20060058869A1 (en) Coiled ladder stent
EP2219565B1 (en) Endoprosthesis having struts linked by foot extensions
CA2417315A1 (en) Stent with enhanced crossability
EP2229127A1 (en) A luminal prosthesis
US20130317597A1 (en) Stent Designs With Angled Connectors
US20090259299A1 (en) Side Branch Stent Having a Proximal Flexible Material Section
EP3538036B1 (en) Stent
JP2005192932A (en) Prosthesis

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION